Department of Nuclear Medicine, Kyungpook National University Hospital, 41944 Daegu, Republic of Korea.
Department of Nuclear Medicine, School of Medicine, Kyungpook National University, 41944 Daegu, Republic of Korea.
J Integr Neurosci. 2022 Apr 2;21(3):74. doi: 10.31083/j.jin2103074.
Sleep disturbance is one of the most common non-motor symptoms of Parkinson's disease (PD). However, the confounding effects of dopaminergic medication on sleep are a major challenge in understanding the impact of sleep disturbance in PD. We investigated the sleep disturbance and associated clinical features in patients with de novo, untreated PD.
One-hundred-eight patients with de novo, untreated PD were included. Night sleep disturbance was evaluated using the night sleep subscale of the Scales for Outcomes in Parkinson's Disease (SCOPA-Sleep). Depression, anxiety, and apathy were assessed using the Geriatric Depression Scale (GDS), Beck Anxiety Inventory (BAI), and Apathy Evaluation Scale (AES), respectively. Early perfusion and dopamine transporter imaging of F-18 FP-CIT PET/CT were performed together with statistical parametric mapping analysis.
The night sleep SCOPA-Sleep sub-score was correlated with the AES ( = 0.014), BAI ( = 0.014), and GDS ( = 0.023) scores. Patients with poor night sleep were more apathetic ( = 0.013). Additionally, there was increased perfusion in the left posterior cingulate in patients with sleep disturbance and apathy compared to those with sleep disturbance only.
Night sleep disturbance was related to mood disorders, particularly apathy, in patients with de novo, untreated PD.
睡眠障碍是帕金森病(PD)最常见的非运动症状之一。然而,多巴胺能药物对睡眠的混杂影响是理解 PD 中睡眠障碍影响的主要挑战。我们研究了未经治疗的初发 PD 患者的睡眠障碍及相关临床特征。
纳入 108 例未经治疗的初发 PD 患者。使用帕金森病结局量表(SCOPA-Sleep)的夜间睡眠子量表评估夜间睡眠障碍。使用老年抑郁量表(GDS)、贝克焦虑量表(BAI)和淡漠评估量表(AES)分别评估抑郁、焦虑和淡漠。同时进行 F-18 FP-CIT PET/CT 的早期灌注和多巴胺转运体成像,并进行统计参数映射分析。
夜间睡眠 SCOPA-Sleep 子量表与 AES(r=0.014)、BAI(r=0.014)和 GDS(r=0.023)评分相关。睡眠较差的患者更淡漠(r=0.013)。此外,与仅睡眠障碍的患者相比,睡眠障碍和淡漠的患者左侧后扣带回的灌注增加。
未经治疗的初发 PD 患者夜间睡眠障碍与情绪障碍,特别是淡漠有关。